LOGIN
Epidural Morphine and Bupivacaine For Post-Op Analgesia After Transforaminal Lumbar Interbody Fusion
June 2025
Epidural Morphine and Bupivacaine For Post-Op Analgesia After Transforaminal Lumbar Interbody Fusion
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
A Randomised Controlled Study on Epidural Morphine and Bupivacaine for Post-Operative Analgesia After Transforaminal Lumbar Interbody Fusion.
Global Spine J . 2023 Sep;13(7):1926-1931.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred patients undergoing transforaminal lumbar interbody fusion (TLIF) for various lumbar pathologies were randomized to receive either an intraoperative epidural instillation of morphine 5 mg with 2 mL of 0.25% bupivacaine and additional 6 mL bupivacaine infiltration into deep fascia (n=50), or no such instillation (n=50). The primary outcome was post-operative pain, assessed using VAS and...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.